An interventional study of Feeding in Childhood Obesity, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 4 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-01.
Sponsored by University of Michigan · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 558 studies in Pediatric Obesity with a site in United States — 72 open to participants now, 109 under way, 3 of them phase 3. Pediatric Obesity · United States.
Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 79th largest by planned enrollment of the 475 interventional ones that give a count, is one of 13 that started in 2026, is one of 423 with no phase, reaches primary completion later than 79 of the 108 other live ones, and was the 553rd registered.
1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.
Browse Pediatric Obesity studies →72 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 10–15
Children's Hospital Los Angeles · Sites in United States
Ages 12–18
Virginia Commonwealth University · Sites in United States
Ages 12–15 · Healthy volunteers
Russell McCulloh, MD · Sites in United States
Ages 12–17
University of Florida · Sites in United States
Ages 16–65 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.
This study: 4 Months and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
558 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 27 · Phase 3 10 · Phase 4 11
First in 1998; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 440 is above the median of 100 across 872 interventional studies indexed under Pediatric Obesity.
Median enrollment 95 across the 475 interventional studies, 120 across the 81 observational. Of the 419 that completed or were terminated, 116 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 558 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 8 studies filed under Pediatric Obesity — fewer than ten, so there is no comparison to draw.
39 of the studies in Pediatric Obesity with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04974554Medical University of South CarolinaFIT Families Multicomponent Obesity Intervention for African American Adolescents | 2026-11-30 |
| NCT06810557Temple UniversityBrief Behavioral Sleep Intervention for Obesity Prevention in Primary Care | 2026-11-30 |
| NCT04971044Vanderbilt University Medical CenterCompetency Based Approaches for Community Health 2 | 2026-12 |
| NCT05067621Yale UniversitySemaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease | 2026-12 |
| NCT04128995Children's Hospital Medical Center, CincinnatiSurgical or Medical Treatment | 2026-12 |
Add all 39 to your calendar (.ics) → With an account.
Among the 558 studies in Pediatric Obesity with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The researchers will study how babies respond to bottle nipples with different flow rates over a few days, and how this may affect how much milk they drink, their feeding patterns, and their sleep.
The study will enroll 220 mother-infant dyads.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Each mother-infant dyad serves as its own control.
Behavioral: Feeding
Following a baseline day (Day 1) in which infants are fed with their typical nipple, infants are exposed to a commercially available nipple with a 30 percent reduced flow rate for three consecutive days (Days 2-4).
Change in milk/formula intake (Δ^(S-T))
Calculated as intake (pre-weight minus post-weight divided by infant body weight) during each slower-flow feeding minus the mean intake across the three baseline feedings
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in suck effect (Δ^(S-T))
Measured with smart bottles and defined as the area under the sucking curve across a single feeding.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in peak tongue pressure ((Δ^(S-T))
Measured with smart bottles and defined as the average peak of the sucking curves across a single feeding.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in sucking frequency (Δ^(S-T))
Measured with smart bottles and defined as the average number of full suck cycles per second across a single feeding.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in sucking smoothness ((Δ^(S-T))
Measured with smart bottles and defined as the average number of sucking pattern peaks in the speed profile of a suck across a single feeding.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in feeding Interval for each of the 12-hour segments post-introduction of the Slower-Flow bottle nipple
Calculated as the mean Feeding Interval during the given 12-hour segment on the Slower Flow day minus the mean Feeding Interval during the matching 12-hour segment Typical nipple day.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in satiation signaling (Δ^(S-T))
Coded set of behaviors from video recordings of feeding interactions associated with infant disengagement from the bottle or caregiver.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Change in dyadic mutuality between infant and caregiver (Δ^(S-T))
Coded from video-recordings of feeding interactions, based on behaviors associated with strong communication, warmth, and synchrony of the dyad.
Time frame: From baseline to the end of the slower flow feeding phase (approximately 4 days later)
Plan to share: Yes — The researchers will upload the study data to Deep Blue Data. Video-recordings and raw sucking data will not be included in the archived data on Deep Blue Data and will only be shared under appropriate data use agreements. "Deep Blue Data provides access to digital research data that were developed or used in the support of research activities at U-M. All data in the repository are available for anyone to download without restriction." https://www.lib.umich.edu/collections/deep-blue-repositories
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Data will be available by August 2029 and the researchers will leave it up a minimum of 3 years.
Access criteria: "All data in the repository are available for anyone to download without restriction." The data not in the repository, ideo-recordings and raw sucking data, University investigators pending approval of data sharing agreement.
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Jul 2028, 25 months after the start.
Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 25 months is close to that.
Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.